Showing results (471-480 of 493) with videos related to
Sort By:
Pageof 50
ACS Medicinal Chemistry Letters|June 6, 2014
Inhibitors of HCV NS5A: From Iminothiazolidinones to Symmetrical StilbenesJeffrey L Romine, Denis R St Laurent, John E Leet, et al.Virology|July 31, 2013
Characterizations of HCV NS5A replication complex inhibitorsDonald R O'Boyle Ii, Jin-Hua Sun, Peter T Nower, et al.Bioorganic & Medicinal Chemistry Letters|June 28, 2013
HCV NS5A replication complex inhibitors. Part 5: discovery of potent and pan-genotypic glycinamide cap derivativesMakonen Belema, Van N Nguyen, Denis R St Laurent, et al.Bioorganic & Medicinal Chemistry Letters|August 7, 2016
Oxazolidinone-based allosteric modulators of mGluR5: Defining molecular switches to create a pharmacological tool boxHong Huang, Andrew P Degnan, Anand Balakrishnan, et al.Neurologia|February 7, 2021
Encephalopathy and encephalitis during acute SARS-CoV-2 infection. Spanish Society of Neurology COVID-19 RegistryM J Abenza Abildúa, S Atienza, G Carvalho Monteiro, et al.Physical Review Letters|August 29, 2014
Reduction of edge-localized mode intensity using high-repetition-rate pellet injection in tokamak H-mode plasmasL R Baylor, N Commaux, T C Jernigan, et al.Neurologia|September 27, 2020
Management of Parkinson's disease and other movement disorders in women of childbearing age: Part 2R García-Ramos, D Santos-García, A Alonso-Cánovas, et al.Neurologia|July 29, 2020
Management of Parkinson's disease and other movement disorders in woman of childbearing age: Part 1R García-Ramos, D Santos-García, A Alonso-Cánovas, et al.Molecular Cancer Therapeutics|June 20, 2015
Novel Anti-TM4SF1 Antibody-Drug Conjugates with Activity against Tumor Cells and Tumor VasculatureAlberto Visintin, Kelly Knowlton, Edyta Tyminski, et al.Public Health Reports (Washington, D.C. : 1974)|November 24, 2025
Acute Care Use Among People With Sickle Cell Disease, Sickle Cell Data Collection Program, 8 US States, 2018Parker Parks, Joshua I Miller, Shamaree Cromartie Jones, et al.Pageof 50